Comerica Securities’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-294
Closed -$49.8K 1194
2022
Q4
$49.8K Buy
+294
New +$53.3K ﹤0.01% 714
2022
Q1
Sell
-806
Closed -$213K 524
2021
Q4
$213K Sell
806
-12
-1% -$3.23K 0.01% 479
2021
Q3
$236K Buy
+818
New +$210K 0.02% 461

Other funds holding RGEN

Comerica Securities's RGEN Position: Q1 2023 in Review

Comerica Securities sold out of Repligen (RGEN) in Q1 2023, closing a stake of 294 shares — an estimated $49.8K sold.

Comerica Securities first reported a position in RGEN in Q3 2021 and held it in 3 quarters. The position peaked at $236K in Q3 2021. 446 funds tracked by Wall St. Rank hold RGEN as of Q1 2023.

  • Comerica Securities reported no remaining Repligen position as of Q1 2023 after selling out during the quarter.
  • Comerica Securities sold 294 Repligen shares in Q1 2023, an estimated $49.8K.
  • Comerica Securities first reported a position in Repligen in Q3 2021 and held it in 3 quarters.
  • Comerica Securities's Repligen position peaked at $236K in Q3 2021.
  • 446 funds tracked by Wall St. Rank held Repligen as of Q1 2023.

Based on Comerica Securities's 13F filing for Q1 2023, filed 27 Apr 2023.